Resources

Resources

Welcome to the Biointron Learning Center

Industry Trends

Biointron Insights: Antibody Industry Report (Q1 2025 Insights, Trends & Analysis)

Biointron’s Q1 2025 annual antibody report aims to explore the events and trends of the biopharmaceutical industry in 2025 (January, February, March).

Mar 31, 2025
Week 2, April 2025: Antibody-Targeted Therapies: A Look at FcRn Inhibitors and Fc Engineering

Just this week, Merida Biosciences emerged from stealth with a $121 million Series A financing to develop a new class of precision therapeutics that eliminate pathogenic antibodies in autoimmune and allergic diseases. With programs targeting Graves’ disease, primary membranous nephropathy, and seve

Apr 08, 2025
April 2025: Affinity Maturation

Affinity maturation is a fundamental process in the adaptive immune response that results in the selection of B cells producing antibodies with increased binding affinity for their target antigen. This process occurs in germinal centers and is driven by somatic hypermutation and selection pressures.

Apr 03, 2025

Upcoming Events

AACR Annual Meeting 2025

Biointron is honored to announce our participation in the AACR Annual Meeting 2025, scheduled for April 25-30, 2025, in ···

Jan 03, 2025
Swiss Biotech Day 2025

Biointron is excited to announce our participation in Swiss Biotech Day 2025, taking place on May 5-6, 2025, in Basel, S···

Jan 04, 2025
BIO KOREA 2025

Biointron is thrilled to announce our participation in BIO KOREA 2025, scheduled for May 7-9, 2025, in Seoul, South Kore···

Jan 04, 2025
shape

Webinars

Biointron x Scientist.com Webinar: Introduction to Bispecific Antibodies and Their Production

In this webinar, Dr. Brady Wu will discuss bispecific antibody drugs and their production.

Apr 18, 2025
Biointron x Carterra Webinar: Innovative Methods Advancing Discovery and Characterization of Antibodies

Biointron is thrilled to collaborate with Carterra to bring you an exclusive live webinar: Innovative Methods Advancing Discovery and Characterization of Antibodies

Mar 19, 2025
Biointron x Antibody Society Webinar: AbDrop™ Speeds: Accelerating Your Antibody Discovery with Single B Solution

Biointron is excited to announce our upcoming collaborative webinar with the Antibody Society, scheduled for June 26th, 2025. This webinar will feature our speaker, Dr. Gang Liu, Associate Director of Biointron. Dr. Liu will delve into the captivating topic of "AbDrop Speeds: Accelerating Your Antibody Discovery with Single B Solution," providing attendees with a rich and informative exploration of the latest trends and advancements in antibody discovery technologies.

Mar 10, 2025

Case Studies

White Paper – Simplified and Humanized: Empowering Fully Human Antibody Discovery with AbDrop™

The demand for fully human therapeutic antibodies continues to grow, driving the need for more efficient discovery platforms.

Feb 07, 2025
Stable Cell Line Generation

Case 1: Tag-Free Vaccine Protein. During the generation of stable cell lines, cells are selected and screened to identify clones that stably express t···

Mar 08, 2024
Afucosylated Antibodies

Biointron has developed our own CHOK1-Fut8KO expression platform for afucosylated antibodies.

Dec 15, 2023

Promotions

Scientist.com Review & Rewards Program

At Biointron,we greatly value your perspective and experiences with our products and services.

Feb 02, 2024
Biocompare Review & Rewards Program

Leave a review of our products or services on Biocompare, your feedback allows us to enhance our offerings to better meet your needs.

Jan 29, 2024
Biointron Launches New Referral Program! 25% OFF on Expression Services

Biointron’s new AbExplorer Referral Program now offers you 25% off on our expression services!

Sep 01, 2023

Brochures

Podcast

Spotlight on Antibodies | Episode 3 | March 1 - 31, 2025

This March, top news includes ion channel and GPCR-driven diseases, affinity maturation, and a look back at SARS-CoV-2, 5 years on.

Spotlight on Antibodies | Episode 2 | February 1 - 28, 2025

This February, top news includes novel antibodies to treat obesity, hereditary angioedema, and B cells.

Spotlight on Antibodies | Episode 1 | January 1 - 31, 2025

This January, top news includes glycoengineering, anti-malarial antibodies, and PROTACs.

Blog

Streamlined Gene-to-Antibody Workflow: High-Yield Recombinant Antibody Expression

High-Throughput Recombinant Antibody Production – Gene to Antibody in 2 WeeksOnce antibody candidates are identified (whether via AbDrop™ or other methods), the next challenge is producing enough of each antibody for validation studies. This is where Biointron’s High-Throughput (HTP) Recomb

Apr 16, 2025
Read time: 10 mins
Watch: 31 Short Videos That Explain Antibody Concepts in Under 5 Minutes

Biointron’s Antibody ABCs video series is a growing collection of concise, technical definitions designed to clarify foundational terms in antibody research and development. Each video in the series breaks down essential concepts, offering clear, concise explanations.Antibody ABCs: Antibody Formula

Apr 14, 2025
Read time: 1 min
What are Recombinant Monoclonal Antibodies? A Biotech Primer

DOI: 10.1533/9781908818041.357Recombinant monoclonal antibodies (rAbs) are synthetic molecules produced in the laboratory to act as specific binding agents to target an antigen. In contrast to conventional monoclonal antibodies produced using hybridoma technology, rAbs are made by recombinant DNA me

Apr 11, 2025

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.